Organon & Co. (NYSE:OGN) Issues 8-K Filing Regarding Earnings Report and Financial Disclosures
Organon & Co. (NYSE:OGN) recently released its 8-K filing, dated February 13, 2025, detailing the financial results for the quarter and full year ended December 31, 2024. In this report, the company disclosed information related to its performance over the past year and upcoming strategies. The following key points were highlighted in the filing: Earnings […]
Organon & Co. (NYSE:OGN) recently released its 8-K filing, dated February 13, 2025, detailing the financial results for the quarter and full year ended December 31, 2024. In this report, the company disclosed information related to its performance over the past year and upcoming strategies. The following key points were highlighted in the filing: Earnings […]
